2022 March Life Sciences Update

Funding Remains Strong

Life Sciences Investment by Region In 2021, the top markets for life sciences VC investment remained the same as the previous year: Boston, San Francisco Bay Area, San Diego and New York City—accounting for $41.3 billion in 2021. There were 29 completed deals for at least $250 billion, of which 20 were VC funding rounds and nine were IPOs. Three-fourths of those large deals occurred in just four markets: Boston (11), San Francisco (7), San Diego (3) and New York City (2).

Life Sciences VC & Public Capital Invested by Region, 2021

$6.6B San Diego

$3.1B New York City

$52.4B Total

$1.4B Washington DC Metro

$18.0B Boston

$2.1B Seattle

$0.8B Salt Lake City

$0.9B New Jersey

$0.2B Montreal

$0.7B Toronto

$1.5B Philadelphia

$0.7B Denver

$13.6B San Francisco Bay Area

$0.4B Vancouver

$0.8B Chicago

$1.1B Los Angeles

$0.5B Raleigh / Durham

Source: PitchBook

6 / CUSHMAN & WAKEFIELD

LIFE SCIENCES 2022 MARCH UPDATE